Drug intelligence / Profile preview

quercetin + selenium nanoparticles

Development stage
Preclinical
Modality
Nanoparticles → Drug Delivery Systems
01

Overview

Quercetin-loaded selenium nanoparticles (Qu-SeNPs) are an experimental nanotherapeutic formulation combining the flavonoid quercetin with selenium nanoparticles to enhance anticancer efficacy and targeted delivery. Investigated primarily for colorectal cancer, Qu-SeNPs exhibit a pH-responsive, sustained release profile that allows for preferential action within the acidic tumor microenvironment. The mechanism of action involves the induction of persistent oxidative stress through the gradual generation of reactive oxygen species (ROS), leading to mitochondrial-mediated apoptosis characterized by the upregulation of Bax and activation of caspase-3. Notably, Qu-SeNPs appear to bypass cell cycle checkpoints and fail to trigger the Nrf-2 antioxidant defense pathway, a key differentiator from conventional chemotherapeutics like cisplatin that may help overcome treatment resistance.

Other names
Quercetin-loaded selenium nanoparticlesQu-SeNP
02

Targets

SKP2BCL-2 (BCL-2 family)

Beyond the preview

Go deeper on quercetin + selenium nanoparticles.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on quercetin + selenium nanoparticles.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call